Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AZN

Astrazeneca plc

Jun 01 • 04:00PM ET

179.71

-5.96 -3.21 %

Healthcare • Drug Manufacturers - General • United Kingdom • Mega • NYSE

Today, 1:02 PMMixed ASCO 2026 data and pipeline questions weigh on AZN shares

Peers: LLY MRK PFE ABBV JNJ NVS GSK BMY SNY AMGN

| Held by: PVAL AVDE DIHP DFIC PPH FVD DFAX BDYN JDVL IDEQ

Scroll to Statements

Index	-	P/E	27.00	EPS (ttm)	6.66	Insider Own	4.82%	Shs Outstand	1.55B	Perf Week	-3.91%
Market Cap	278.70B	Forward P/E	15.41	EPS next Y	11.66	Insider Trans	-0.02%	Shs Float	1.48B	Perf Month	-4.09%
Enterprise Value	305.00B	PEG	1.24	EPS next Q	2.50	Inst Own	58.01%	Short Float	0.15%	Perf Quarter	-11.79%
Income	10.39B	P/S	4.61	EPS this Y	12.16%	Inst Trans	-14.88%	Short Ratio	1.12	Perf Half Y	-4.66%
Sales	60.44B	P/B	5.89	EPS next Y	13.51%	ROA	9.43%	Short Interest	2.16M	Perf YTD	2.40%
Book/sh	30.52	P/C	36.31	EPS next 5Y	12.42%	ROE	23.51%	52W High	212.71 -15.51%	Perf Year	27.00%
Cash/sh	4.95	P/FCF	23.84	EPS past 3/5Y	45.90% 22.05%	ROIC	14.17%	52W Low	134.90 33.22%	Perf 3Y	21.67%
Dividend Est.	3.35 (1.86%)	EV/EBITDA	15.36	Sales past 3/5Y	9.82% 16.31%	Gross Margin	74.32%	Volatility	1.57% 1.61%	Perf 5Y	62.27%
Dividend TTM	3.20 (1.78%)	EV/Sales	5.05	EPS Y/Y TTM	33.66%	Oper. Margin	23.23%	ATR (14)	3.76	Perf 10Y	208.52%
Dividend Ex-Date	Feb 20, 2026	Quick Ratio	0.71	Sales Y/Y TTM	9.93%	Profit Margin	17.19%	RSI (14)	37.31	Recom	1.57
Dividend Gr. 3/5Y	1.78% 3.25%	Current Ratio	0.91	EPS Q/Q	5.63%	SMA20	-2.65%	Beta	0.29	Target Price	223.87
Payout	47.19%	Debt/Eq	0.72	Sales Q/Q	12.51%	SMA50	-5.76%	Rel Volume	1.50	Prev Close	185.67
Employees	96100	LT Debt/Eq	0.55	Earnings	Apr 29 BMO	SMA200	0.16%	Avg Volume	1.93M	Price	179.71
IPO	Oct 17, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.34% 2.38%	Trades		Volume	2,892,533	Change	-3.21%

Today 10:19AM	AIM Stock Soars Over 200% As Pancreatic Cancer Trial Hits Enrollment Milestone Early CEO Sees 'Value-Inflection Period' Ahead (Stocktwits)
10:19AM	AIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule CEO Sees 'Significant Value-Inflection Period' Ahead (Stocktwits)
09:57AM	ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do (Proactive)
05:06AM	AstraZeneca aims for a new blockbuster run in cardio disease (Pharma Voice)
May-29-26 10:33AM	US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial (Proactive)
06:17AM	Loading…
06:17AM	Allogene CEO to step down; Agios drug fails key test (BioPharma Dive)
May-28-26 02:16AM	FTSE 100 Live: London stocks flop as oil and bonds kick back up on Hormuz tensions (Proactive)
May-27-26 11:30PM	SLS Stock Extends Rally Overnight: CEO Says Bullish Leukemia Data Could Drive NCCN Recognition For GPS (Stocktwits)
10:09AM	FDA delays decision on AstraZeneca breast cancer pill (BioPharma Dive)
May-26-26 06:16AM	Astellas eyes more cost cuts; FDA panel to debate Moderna vaccine (BioPharma Dive)
May-25-26 06:06AM	AstraZeneca, Daiichi Sankyo's Datroway receives FDA approval for TNBC (Pharmaceutical Business Review)
May-21-26 05:38AM	Lillys triple-acting obesity drug hits goal in Phase 3 trial (BioPharma Dive)
May-20-26 05:06AM	Big Pharma is gambling on specialized R&D. Will it pay off? (Pharma Voice)
May-18-26 09:02AM	AstraZeneca Wins FDA Approval for $5 Billion Blood Pressure Drug (GuruFocus.com)
08:04AM	FDA approves AstraZenecas new kind of hypertension drug (BioPharma Dive)
07:00AM	Loading…
07:00AM	BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension (Business Wire)
02:53AM	AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu (Proactive)
02:15AM	FTSE 100 Live: Stocks spike on reports of progress in Iran-US negotiations (Proactive)
May-15-26 07:36AM	Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers (BioPharma Dive)
May-14-26 07:00AM	Perioperative IMFINZI (durvalumab) plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial (Business Wire)
May-13-26 07:28AM	UAE approves AstraZeneca's Baxfendy for hypertension (Pharmaceutical Business Review)
05:00AM	Why the FDAs push for real-time clinical trials could favor Big Pharma (Pharma Voice)
02:17AM	FTSE 100 Live: London stocks in red, Babcock gains offset by bond worries over Starmer (Proactive)
May-11-26 06:00PM	PRIMECAP Management's Strategic Moves: AstraZeneca PLC Exits with a -2.57% Impact (GuruFocus.com)
May-07-26 11:34AM	Why This Income Pro Likes Banks, Chip-Equipment Companies, and More (Barrons.com)
May-06-26 07:07PM	Ken Fisher's Strategic Moves: AstraZeneca PLC Leads the Portfolio Additions (GuruFocus.com)
May-01-26 08:28AM	Summits self-inflicted stumble; Esperions take-private deal (BioPharma Dive)
08:10AM	AstraZeneca stock sinks after FDA advisers vote against its breast cancer drug (Quartz)
08:01AM	AstraZeneca stock falls after FDA panel rejects breast cancer drug (Quartz)
05:48AM	AstraZeneca shares drop after US regulators vote against breast cancer drug (Reuters Videos)
04:46AM	Loading…
04:46AM	AstraZeneca falls as FDA advisers reject breast cancer drug use (Proactive)
04:06AM	AstraZeneca slips after FDA panel rejects breast cancer drug camizestrant (Investing.com)
Apr-30-26 09:42PM	TRUQAP (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer (Business Wire)
08:32AM	Citi raises AstraZeneca earnings forecast and maintains 'buy' rating ahead of second-half pipeline catalysts (Proactive)
Apr-29-26 07:00PM	Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca (PR Newswire)
12:12PM	AstraZeneca to invest £300m in Britain as Starmer pays more for drugs (The Telegraph)
11:12AM	AstraZeneca beats Q1 estimates, CEO says drug pipeline is 'delivering' (Yahoo Finance Video)
08:06AM	Astrazeneca tops expectations in the first quarter on strong cancer drug sales (Associated Press)
07:58AM	AstraZeneca Q1 2026 earnings beat on cancer drug sales (Quartz)
07:21AM	FDA tests out real-time clinical trials; AbbVie closes in on a KRAS biotech (BioPharma Dive)
06:09AM	American industry is winning: White House touts factory boom how investors can ride the reshoring wave (Moneywise)
03:09AM	AstraZeneca tops Q1 forecasts on strong cancer, rare-disease drug demand (Investing.com)
02:36AM	Astrazeneca: Q1 Earnings Snapshot (Associated Press)
02:16AM	FTSE 100 Live: Stocks sink as oil pushes 4yr highs, AstraZeneca, GSK, Lloyds report (Proactive)
02:16AM	FTSE 100 Live: Sluggish start as AstraZeneca, Haleon results disappoint (Proactive)
02:03AM	AstraZeneca sticks to its guns after strong first-quarter revenue growth (Proactive)
Apr-28-26 03:00PM	FDA is launching real-time monitoring of drug trials, with AstraZeneca and Amgen as first test cases (Quartz)
09:15AM	Earnings To Watch: AstraZeneca PLC (LSE:AZN) Reports Q1 2026 Result (GuruFocus.com)
05:55AM	FDA approves AstraZeneca's Saphnelo for SLE (Pharmaceutical Business Review)
02:06AM	FTSE 100 Live: Barclays leads blue-chips lower after results, oil hits $110 a barrel (Proactive)
Apr-27-26 08:04AM	Citi sees Daiichi supply review as immaterial for AstraZeneca (Proactive)
07:00AM	SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus (Business Wire)
Apr-21-26 01:01PM	T Rowe Price Equity Income Fund's Strategic Moves: AstraZeneca PLC Takes Center Stage (GuruFocus.com)
08:03AM	AstraZeneca's tozorakimab treble puts $5bn sales ceiling in sight, says Citi (Proactive)
03:16AM	AstraZeneca's Ultomiris hits primary endpoint in rare kidney disease trial (Proactive)
02:16AM	FTSE 100 Live: Stocks open flat as market awaits signals on Iran-US talks (Proactive)
02:16AM	FTSE 100 Live: London stocks mixed as bond markets eye Starmer pressure (Proactive)
Apr-20-26 07:00AM	Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD (Business Wire)
Apr-17-26 06:44AM	The innovators working to make in vivo cell therapy a reality (Pharmaceutical Technology)
Apr-15-26 03:17AM	FTSE 100 Live: Shares mixed as Iran talks awaited, Ceres and Rank jump (Proactive)
Apr-13-26 12:48PM	GSK Plans Five Late-Stage Cancer Trials As Shares Rise Nearly 50% (GuruFocus.com)
Apr-10-26 05:01PM	Parnassus Value Equity Fund's Strategic Moves: AstraZeneca PLC Takes Center Stage (GuruFocus.com)
10:31AM	AstraZeneca faces China headwinds and key drug launches as two banks back 20% upside (Proactive)
Apr-08-26 08:09AM	Virginia governor signs 4 laws establishing manufacturing grant programs (Manufacturing Dive)
Apr-07-26 07:15AM	FTSE 100 Live: Defence and gold miners drag as Trump's new Iran deadline awaited (Proactive)
07:00AM	AstraZeneca's liver cancer breakthrough puts Imfinzi on course to become a super-blockbuster drug (Proactive)
Apr-01-26 09:15AM	US bank sees AstraZeneca HPP drug data as supportive of $2.6bn forecast with upside to $4.4bn despite mixed trial results (Proactive)
Mar-31-26 03:45PM	$2 Billion Bayer Verdict: What the Roundup Decision Means for MAHA (Exec Edge)
09:04AM	Lilly's $2 Billion AI Deal Raises Stakes (GuruFocus.com)
Mar-30-26 10:15AM	Tozorakimab trial success hands AstraZeneca a crucial edge in the race to crack COPD's hardest-to-treat patients (Proactive)
05:23AM	FTSE 100 Live: Blue-chip index climbs as oil price rises but bonds ease (Proactive)
02:03AM	Connecting Excellence Group appoints chief performance and growth officer (Proactive)
Mar-27-26 07:00AM	Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD (Business Wire)
04:41AM	AstraZeneca shares rise to top of FTSE 100 as COPD drug clears two pivotal trials (Proactive)
Mar-26-26 03:00PM	Innate Pharma SA (IPHA) Full Year 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Mar-24-26 10:30AM	Advancements in Novel Immunotherapeutics in The Oncology Battle (Newsfile)
Mar-19-26 11:39AM	Long-only funds are buying non-US stocks, BofA says (Investing.com)
03:22AM	AstraZeneca to boost cell therapy capabilities with new China investment (BioPharma Dive)
Mar-18-26 02:29PM	Analysis-TrumpRx lists many medicines at prices higher than paid in UK (Reuters)
Mar-16-26 07:02AM	Building materials giant abandons London stock market (The Telegraph)
07:02AM	£50bn construction giant abandons London stock market (The Telegraph)
Mar-12-26 02:55PM	Abivax Pushes Back On Takeover Rumors (Moby)
03:33AM	Poolbeg Pharma adds CAR-T therapy expert to scientific advisory board (Proactive)
Mar-10-26 08:30AM	AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer (Business Wire)
Mar-09-26 09:35AM	Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026? (Zacks)
07:00AM	ENHERTU (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer (Business Wire)
02:30AM	ENHERTU Granted Priority Review in the U.S. as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer (Business Wire)
Mar-06-26 06:37PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
09:50AM	Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term (Zacks)
08:21AM	Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4? (Zacks)
07:17AM	Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial (Proactive)
05:22AM	The Zacks Analyst Blog Highlights Exxon Mobil, Palantir, AstraZeneca, Gencor Industries and Hour Loop (Zacks)
Mar-05-26 04:31PM	Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca (Zacks)
09:40AM	Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term (Zacks)
08:45AM	Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations? (Zacks)
06:00AM	Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor (Benzinga)
Mar-03-26 08:03PM	Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
10:05AM	Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead? (Zacks)
Mar-02-26 06:51PM	Salesforce CEO touts company resilience amid software slump (TheStreet)
12:31PM	Compugen Ltd. Q4 2025 Earnings Call Summary (Moby)

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

M.B.A.Mr. Pascal Claude Roland Soriot D.V.M.

CFO & Executive DirectorDr. Aradhana Sarin M.D.

EVP of Global opt. & ITMs. Pam P. Cheng

Head of Investor RelationsMr. Joris Silon

CHROMr. Jeffrey Pott J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sharma Mani	See Remarks	May 20 '26	Sale	185.78	11,893	2,209,482	19,262	May 22 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc

Upgrade your Finviz experience